InvestSMART

Entropy Neurodynamics Limited (ASX: ENP) - Announcements

Current share price for ENP : $0.029 0.002 (6.45%)+

ASX company news and announcements for Entropy Neurodynamics Limited (ENP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Entropy Neurodynamics Limited (ENP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Entropy Neurodynamics Limited (ENP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Entropy Neurodynamics Limited (ENP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$47 Quarterly Activities Report and Appendix 4C 28 Oct 2026 8:21AM $0.030 $0.029 fallen by 3.33%
$47 Entropy presents promising TRP-8803 clinical data at ECNP 19 Oct 2026 8:46AM $0.035 $0.029 fallen by 17.14%
$47 Change of Director's Interest Notice - HJ 14 Oct 2026 12:13PM $0.036 $0.029 fallen by 18.31%
$47 Cleansing Notice 14 Oct 2026 12:10PM $0.036 $0.029 fallen by 18.31%
$47 Application for quotation of securities - ENP 14 Oct 2026 12:07PM $0.036 $0.029 fallen by 19.44%
$47 TRP-8803 60-Minute Infusion Achieved in Phase 2 BED Study 7 Oct 2026 9:11AM $0.038 $0.029 fallen by 23.68%
$47 2026 AGM Notice of Meeting, Letter of Access and Proxy 5 Oct 2026 8:50AM $0.039 $0.029 fallen by 25.64%
$47 Notification regarding unquoted securities - ENP 2 Oct 2026 3:16PM $0.039 $0.029 fallen by 25.64%
$47 Notification of Date of 2026 AGM 15 Sep 2026 8:43AM $0.041 $0.029 fallen by 29.27%
$47 All Patients Improve, 50% Achieve 12-Week BED Remission 14 Sep 2026 8:40AM $0.040 $0.029 fallen by 27.50%
$47 Investor Webinar Presentation 28 Aug 2026 10:03AM $0.041 $0.029 fallen by 29.27%
$47 Appendix 4G and Corporate Governance Statement 28 Aug 2026 9:46AM $0.041 $0.029 fallen by 29.27%
$47 Appendix 4E and 2026 Annual Report 28 Aug 2026 9:44AM $0.041 $0.029 fallen by 29.27%
$47 Entropy Advances TRP-8803 to US Phase 2 in Depression 26 Aug 2026 9:57AM $0.039 $0.029 fallen by 25.64%
$47 Application for quotation of securities - ENP 24 Aug 2026 4:18PM $0.039 $0.029 fallen by 25.64%
$47 Trading Halt 24 Aug 2026 9:39AM $0.039 $0.029 fallen by 25.64%
$47 TRP 8803 manufacturing secured for Phase 2/3 advancement 19 Aug 2026 8:20AM $0.037 $0.029 fallen by 21.62%
$47 Change of Director's Interest Notice - HJ 7 Aug 2026 1:47PM $0.036 $0.029 fallen by 19.44%
$47 Cleansing Notice 7 Aug 2026 9:49AM $0.037 $0.029 fallen by 20.55%
$47 Application for quotation of securities - ENP 7 Aug 2026 9:44AM $0.037 $0.029 fallen by 20.55%
$47 BioShares 2026 Investor Presentation Deck 7 Aug 2026 8:53AM $0.037 $0.029 fallen by 20.55%
$47 72-Patient Trial Fast-Tracks TRP-8803 Commercialisation 4 Aug 2026 9:10AM $0.035 $0.029 fallen by 17.14%
$47 Trading Halt 31 Jul 2026 9:17AM $0.035 $0.029 fallen by 17.14%
$47 Techknow Invest Roadshow presentation 27 Jul 2026 9:12AM $0.037 $0.029 fallen by 21.62%
$47 Appointment of Joint Company Secretary 24 Jul 2026 2:06PM $0.037 $0.029 fallen by 21.62%

1 - 25 of 80 results

Page 1 of 4

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.